81 related articles for article (PubMed ID: 19121844)
1. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer.
Rather TB; Parveiz I; Bhat GA; Rashid G; Wani RA; Khan IY; Mudassar S
Clin Exp Med; 2023 Oct; 23(6):2385-2405. PubMed ID: 36318377
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.
Wu HY; Luo LF; Wei F; Jiang HM
World J Surg Oncol; 2023 Nov; 21(1):366. PubMed ID: 38001498
[TBL] [Abstract][Full Text] [Related]
4. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
[TBL] [Abstract][Full Text] [Related]
5. An integrated model of CDCA5 and FOXM1 expression combined with a residual disease that predicts prognosis in ovarian cancer patients.
Zhang Q; Zhang R; Liu M; Wu H; Yang B
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):143-149. PubMed ID: 37953569
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.
Ma J; Qi G; Xu J; Ni H; Xu W; Ru G; Zhao Z; Xu W; He X
Oncol Lett; 2017 Dec; 14(6):7288-7296. PubMed ID: 29344165
[TBL] [Abstract][Full Text] [Related]
7. Centromere protein F and Forkhead box M1 correlation with prognosis of non-small cell lung cancer.
Li R; Wang X; Zhao X; Zhang X; Chen H; Ma Y; Liu Y
Oncol Lett; 2020 Feb; 19(2):1368-1374. PubMed ID: 31966068
[TBL] [Abstract][Full Text] [Related]
8. Correlation of HER2 and FOXM1 in human colorectal carcinoma and its clinical significance.
Lu M; Hu K
Int J Clin Exp Pathol; 2017; 10(12):11624-11634. PubMed ID: 31966520
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of forkhead box M1, cyclooxygenase-2
Bai J; Li Y; Cai L
World J Clin Cases; 2023 Oct; 11(30):7284-7293. PubMed ID: 37969442
[TBL] [Abstract][Full Text] [Related]
10. Effect of taxol on the expression of
Liu Z; Xiao YU; Ning S; Li ZY; Zhu Y; Hu G
Oncol Lett; 2016 Jun; 11(6):4035-4039. PubMed ID: 27313736
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma.
Hino Y; Kohashi K; Tamaki A; Kawakubo N; Hamada H; Fukuhara M; Shibui Y; Tajiri T; Oda Y
Pathol Res Pract; 2024 May; 258():155348. PubMed ID: 38761648
[TBL] [Abstract][Full Text] [Related]
12. Correction: ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.
Cui M; Chang Y; Wang J; Wu J; Li G; Tan J
Cell Death Discov; 2023 Aug; 9(1):322. PubMed ID: 37644015
[No Abstract] [Full Text] [Related]
13. FoxM1: a master regulator of tumor metastasis.
Raychaudhuri P; Park HJ
Cancer Res; 2011 Jul; 71(13):4329-33. PubMed ID: 21712406
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors.
Lee HW; Lee EH; Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Hwang IS; Roh MS; Seo JW
Pathol Int; 2012 Sep; 62(9):583-91. PubMed ID: 22924844
[TBL] [Abstract][Full Text] [Related]
15. A different TRAP220 expression in distinct histologic subtypes of lung adenocarcinoma and the prognostic significance.
Yun J; Son CH; Um SJ; Kwon HC; Lee KE; Choi PJ; Roh MS
Lung Cancer; 2011 Mar; 71(3):312-8. PubMed ID: 20650541
[TBL] [Abstract][Full Text] [Related]
16. Cytologic Features of Pulmonary Langerhans Cell Histiocytosis in Bronchial Washing: A Report of Two Cases.
Kang M; Ha SY; Roh MS
J Cytol; 2019; 36(2):131-132. PubMed ID: 30992652
[No Abstract] [Full Text] [Related]
17. Melanoma pathology reporting and staging.
Scolyer RA; Rawson RV; Gershenwald JE; Ferguson PM; Prieto VG
Mod Pathol; 2020 Jan; 33(Suppl 1):15-24. PubMed ID: 31758078
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
Roh MS; Lee JH; Kang KW; Nam HY; Jung SB; Kim K; Lee EH; Park MI; Kim MS; Lee HW
Virchows Arch; 2015 Dec; 467(6):667-673. PubMed ID: 26445970
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1/cip1) in the diagnosis of pulmonary neuroendocrine tumours.
Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Lee EH; Roh MS; Seo B
Histopathology; 2012 Apr; 60(5):731-9. PubMed ID: 22296117
[TBL] [Abstract][Full Text] [Related]
20. FOXM1: a new therapeutic target of extramammary Paget disease.
Ito T; Tanaka Y; Kaku-Ito Y; Oda Y; Nakahara T
Sci Rep; 2024 Feb; 14(1):4048. PubMed ID: 38374400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
